“Personalized Care With DPP4i SGLT2i Strategy As Initial-Line in the Management of Type 2 Diabetes Mellitus With Cardiovascular Risk: DELPHI Statement”. 2024. Cardiology and Cardiovascular Medicine 8 (2): 111-17. https://fortunejournals.org/ojs/index.php/ccm/article/view/16470.